Development of New Technologies Needed for Studying the Human Microbiome (R21)

The summary for the Development of New Technologies Needed for Studying the Human Microbiome (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Development of New Technologies Needed for Studying the Human Microbiome (R21): -Purpose. The purpose of this FOA is to solicit applications to develop new and improved technologies for obtaining samples for sequencing, by culturing or otherwise isolating for analysis currently uncultivatable organisms from the human microbiota. -Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Grant (R21) award mechanism and runs in parallel with an FOA of identical scientific scope, RFA RM-08-010, that solicits applications under the R01 mechanism. -Funds Available and Anticipated Number of Awards. $2 million is available in FY08 for this FOA and the parallel R01 FOA in combination. It is anticipated that 2-6 R21 grants and 2-4 R01 grants will be awarded. R21 applications may request up to $275,000 direct costs over 2 years, with no more than $200,000 in direct costs allowed in any single year. The R21 is not renewable. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Federal Grant Title:	Development of New Technologies Needed for Studying the Human Microbiome (R21)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-RM-08-011
Type of Funding:	Grant
CFDA Numbers:	93.310
CFDA Descriptions:	Trans-NIH Research Support
Current Application Deadline:	No deadline provided
Original Application Deadline:	Feb 15, 2008
Posted Date:	Dec 12, 2007
Creation Date:	Dec 12, 2007
Archive Date:	Mar 17, 2008
Total Program Funding:	$2,000,000
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education State governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled "Additional Information on Eligibility" for clarification) County governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial No...; • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...; • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional); • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional); • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional); • Using Metabolomics to Investigate Biological Pathways and Networks (R01); • Assay Development for High Throughput Molecular Screening (R21); • Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health: • Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Opti...; • Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Opti...; • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required); • Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans...; • Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)